Mylan faces federal antitrust investigator in EpiPen business

Federal antitrust regulators are eyeing big drugmaker Mylan's EpiPen business, the company said this week. Mylan, in a statement, said the Federal Trade Commission asked it "months ago" for information about its anti-allergy EpiPen "as part of a preliminary investigation." The disclosure comes nearly five months after two United States senators asked the FTC to investigate whether Mylan violated antitrust laws to protect the auto-injector EpiPen from competition.
Read more: http://www.nbcnews.com/business/business-news/epipen-maker-mylan-faces-federal-antitrust-investigator-n714661?source=Snapzu